China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018

Thursday, March 7, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES 

For the Three Months Ended

December 31,

December 31,

2018

2017

USD

USD

Income from Operations

42,644,418

19,594,582

Non-cash employee share-based compensation

(4,563,509)

9,187,749

Amortization of acquired intangible assets and land use rights

1,750,585

-

Expenses related to change of domicile and acquisition of TianXinFu

-

1,872,012

Adjusted Income from Operations - Non GAAP

39,831,494

30,654,343

Net Income Attributable to the Company

34,907,015

(24,644,413)

Non-cash employee share-based compensation

(5,419,386)

8,396,403

Income tax expense related to U.S. Tax Reform

-

40,290,367

Amortization of acquired intangible assets and land use rights

1,190,398

-

Expenses related to change of domicile and acquisition of TianXinFu

-

1,872,012

Adjusted Net Income Attributable to the Company - Non GAAP

30,678,027

25,914,369

Diluted EPS - Non GAAP

0.76

0.90

Weighted average number of shares used in computation of Non GAAP diluted EPS

39,452,458

27,812,319

For the Years Ended

December 31,

December 31,

2018

2017

USD

USD

Income from Operations

146,172,751

135,858,505

Non-cash employee share-based compensation

23,130,570

33,903,283

Amortization of acquired intangible assets and land use rights

8,366,196

-

Expenses related to change of domicile and acquisition of TianXinFu

-

1,872,012

Adjusted Income from Operations - Non GAAP

177,669,517

171,633,800

Net Income Attributable to the Company

128,056,302

67,943,035

Non-cash employee share-based compensation

19,706,585

31,108,910

Amortization of acquired intangible assets and land use rights

5,689,013

-

Income tax expense (benefit) related to U.S. Tax Reform

(7,519,674)

40,290,367

Expenses related to change of domicile and acquisition of TianXinFu

-

1,872,012

Adjusted Net Income Attributable to the Company - Non GAAP

145,932,226

141,214,324

Diluted EPS - Non GAAP

4.02

4.95

Weighted average number of shares used in computation of Non GAAP diluted EPS

35,432,959

27,605,623



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store